Longevity Treatments That Have Clinical Evidence

The longevity space has an honesty problem. For every intervention with genuine clinical evidence, there are ten being marketed on hope and hype. If you're going to invest in living longer and living better, you deserve to know what actually has data behind it.

Here's a clear-eyed look at the longevity treatments and interventions that have real clinical or strong preclinical support — and a few that don't deserve the attention they're getting.

What "Longevity Treatment" Actually Means

Let's define terms. Longevity interventions fall into two categories: lifespan (how long you live) and healthspan (how well you live during those years). Most of the actionable interventions available today target healthspan — keeping your body, brain, and metabolic function performing at a high level as you age.

The distinction matters because very few interventions have been proven to extend maximum human lifespan. What several interventions can do is meaningfully slow the functional decline that typically accelerates after 40.

NAD+ Precursors

What they are: Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in every cell of your body. It's essential for energy metabolism, DNA repair, and cellular signaling. NAD+ levels decline significantly with age — roughly 50% by middle age.

The evidence: Research published in journals including Cell Metabolism and Nature Aging has demonstrated that restoring NAD+ levels through precursors (NMN and NR) can improve mitochondrial function, enhance DNA repair mechanisms, and improve metabolic markers in animal studies. Human trials are showing promising results for improvements in muscle function, insulin sensitivity, and cardiovascular health, though large-scale long-term data is still accumulating.

The clinical approach: NAD+ can be supplemented orally (via NMN or NR) or delivered intravenously for higher bioavailability. Physician-guided protocols typically include baseline and follow-up testing to measure response.

Metformin

What it is: The most widely prescribed diabetes medication in the world, now being studied specifically for anti-aging properties.

The evidence: Observational data has been striking — diabetic patients taking metformin appear to have lower all-cause mortality than non-diabetic controls in some studies. The TAME (Targeting Aging with Metformin) trial is currently the largest clinical trial specifically investigating metformin as a longevity intervention. Proposed mechanisms include improved insulin sensitivity, reduced inflammation, and activation of AMPK pathways involved in cellular maintenance.

The caveat: Some evidence suggests metformin may blunt the benefits of exercise on muscle growth and mitochondrial adaptation. This is still debated in the research, but it's worth discussing with your physician if you're highly active.

Rapamycin (Low-Dose)

What it is: An mTOR inhibitor originally used as an immunosuppressant. At low, intermittent doses, it's being explored as a longevity intervention.

The evidence: Rapamycin has the most robust lifespan extension data of any drug in animal models. Multiple independent studies have shown significant lifespan increases in mice. The proposed mechanism — modulation of the mTOR pathway — is one of the most well-characterized aging pathways in molecular biology.

The reality: Human longevity data doesn't exist yet. Low-dose protocols are being used by some longevity-focused physicians, but this remains an area where preclinical evidence significantly outpaces clinical validation. Potential side effects at higher doses (immunosuppression, metabolic changes) require careful monitoring.

Growth Hormone Optimization

What it is: Using peptides like sermorelin or tesamorelin to stimulate your body's natural growth hormone production, rather than supplementing with synthetic HGH directly.

The evidence: Growth hormone levels decline approximately 14% per decade after age 30. Research has linked this decline to increased body fat, decreased muscle mass, reduced bone density, impaired sleep quality, and cognitive decline. Clinical studies on growth hormone secretagogues have shown improvements in body composition, sleep architecture, and recovery markers.

Why secretagogues over HGH: Direct growth hormone supplementation bypasses your body's feedback mechanisms and carries risks including insulin resistance and joint pain. Secretagogues work with your pituitary gland to produce growth hormone within physiological ranges, maintaining natural pulsatile release patterns.

What Has Less Evidence Than You'd Think

Telomere-focused interventions: While telomere length is associated with aging, interventions specifically targeting telomere extension haven't demonstrated meaningful clinical benefit yet.

Most "anti-aging" supplements: The majority of supplements marketed for longevity — from resveratrol to generic antioxidant blends — have failed to show significant benefits in well-designed human trials.

Stem cell therapies (as currently marketed): While regenerative medicine has genuine promise, most commercially available stem cell treatments lack rigorous clinical validation for longevity claims.

The Foundation Still Matters

No pharmaceutical or peptide intervention can compensate for poor sleep, chronic stress, sedentary behavior, or a processed diet. The clinical data consistently shows that the highest-impact longevity interventions remain: consistent exercise (both resistance and cardiovascular), 7-9 hours of quality sleep, a whole-food diet, stress management, and strong social connections.

Medical interventions work best as a layer on top of that foundation — not as a replacement for it.

[Learn more about our treatments](/treatments) or [start your intake today](/start).